Health Resources 4

OvaRex MAb is a monoclonal antibody – a biotech drug – designed to help the patient’s immune system recognize and more effectively fight ovarian cancer. OvaRex MAb is given during the ‘watchful waiting’ period, following successful front-line therapy. It may become recognized as the most significant advance in ovarian cancer treatment since the use of chemotherapy to treat this illness.

Millions of people all over the world are affected by these dreaded diseases and majority of people are ignorant about the cure and its treatment and thus leads to most of the death in many countries. These cells have the aptitude to invade additional normal tissues. This disease occurs either by the insertion into the isolated sites by the metastasis or by the direct growth into the contiguous tissue throughout the invasion.